Renaissance Technologies - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$50
-88.1%
71,700
-84.7%
0.00%
-100.0%
Q1 2023$419
+15.4%
467,682
+52.2%
0.00%
Q4 2022$363
-100.0%
307,300
+131.3%
0.00%
-100.0%
Q3 2021$888,000
+210.5%
132,884
+295.2%
0.00%
Q2 2021$286,000
-69.8%
33,625
-68.5%
0.00%
-100.0%
Q1 2021$946,000
-48.7%
106,884
-60.6%
0.00%
-50.0%
Q1 2020$1,844,000
-13.5%
271,184
+89.5%
0.00%0.0%
Q4 2019$2,133,000
+3.3%
143,129
-28.9%
0.00%0.0%
Q3 2019$2,064,000
-34.8%
201,329
-32.6%
0.00%
-33.3%
Q2 2019$3,165,000
-18.8%
298,613
+7.1%
0.00%
-25.0%
Q1 2019$3,899,000
+51.6%
278,929
+10.2%
0.00%
+33.3%
Q4 2018$2,572,000
-23.1%
253,129
-9.2%
0.00%0.0%
Q3 2018$3,346,000
-24.4%
278,813
-29.3%
0.00%
+50.0%
Q2 2018$4,425,000
+173.8%
394,258
+140.4%
0.00%0.0%
Q1 2018$1,616,000
+19.4%
164,029
+69.1%
0.00%
+100.0%
Q4 2017$1,353,000
+55.7%
97,013
+22.8%
0.00%0.0%
Q3 2017$869,000
+369.7%
79,013
+237.3%
0.00%
Q2 2017$185,00023,4250.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders